Oral immunotherapy: The answer to peanut allergy?

Rachel M. Whitsel; Jaclyn A. Bjelac; Ahila Subramanian; Alice E. W. Hoyt; Sandra J. Hong

doi:10.3949/ccjm.88a.20130

ABSTRACT

Peanut and tree-nut allergies have increased dramatically in prevalence, especially in children. Historically, children with food allergies have been treated through strict avoidance of the allergen. Recently, an oral preparation of peanut allergen (Palforzia) was approved for immunotherapy (ie, desensitization) in children 4 to 17 years old. This article reviews oral immunotherapy and its role in children with peanut allergies.

View Full Text

Rachel M. Whitsel, APRN

Department of Allergy and Clinical Immunology, Food Allergy Center of Excellence., Cleveland Clinic

20561-jaclyn-bjelacJaclyn A. Bjelac, MD

Department of Pediatric Allergy and Clinical Immunology, Food Allergy Center of Excellence, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

18335-ahila-subramanianAhila Subramanian, MD

Department of Allergy and Clinical Immunology, Food Allergy Center of Excellence, Cleveland Clinic

23830-alice-hoytAlice E. W. Hoyt, MD

Department of Allergy and Clinical Immunology, Food Allergy Center of Excellence, Cleveland Clinic; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

6675-sandra-hongSandra J. Hong, MD⇑

Department of Allergy and Clinical Immunology, Food Allergy Center of Excellence, Cleveland Clinic; Clinical Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Address:
Sandra J. Hong, MD, Department of Allergy and Clinical Immunology, Food Allergy Center of Excellence, ST30, Cleveland Clinic Strongsville Family Health Center, 16761 S Park Center, Strongsville, OH 44136; hongs3{at}ccf.org